Geneos Wealth Management’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.24M Sell
8,465
-408
-5% -$62.9K 0.03% 459
2025
Q4
$1.37M Buy
8,873
+1,042
+13% +$156K 0.03% 426
2025
Q3
$1.09M Sell
7,831
-802
-9% -$109K 0.03% 464
2025
Q2
$1.16M Sell
8,633
-44,847
-84% -$6.06M 0.03% 495
2025
Q1
$7.81M Buy
53,480
+46,833
+705% +$6.8M 0.11% 222
2024
Q4
$914K Buy
6,647
+119
+2% +$17.4K 0.03% 442
2024
Q3
$1.01M Sell
6,528
-234
-3% -$35.5K 0.04% 409
2024
Q2
$985K Sell
6,762
-225
-3% -$32.3K 0.04% 362
2024
Q1
$1.03M Sell
6,987
-17,112
-71% -$2.45M 0.05% 341
2023
Q4
$3.29M Sell
24,099
-110
-0.5% -$14.3K 0.16% 155
2023
Q3
$3.12M Buy
24,209
+17,731
+274% +$2.35M 0.16% 156
2023
Q2
$860K Buy
6,478
+286
+5% +$37.7K 0.05% 341
2023
Q1
$802K Sell
6,192
-40,188
-87% -$5.25M 0.05% 343
2022
Q4
$6.3M Buy
46,380
+30,395
+190% +$4.03M 0.38% 56
2022
Q3
$1.94M Sell
15,985
-33,959
-68% -$4.37M 0.13% 166
2022
Q2
$6.48M Sell
49,944
-583
-1% -$76.4K 0.32% 64
2022
Q1
$6.92M Buy
50,527
+41,459
+457% +$5.49M 0.3% 70
2021
Q4
$1.28M Buy
9,068
+285
+3% +$37.8K 0.05% 337
2021
Q3
$1.12M Buy
8,783
+747
+9% +$98.7K 0.04% 351
2021
Q2
$1.03M Sell
8,036
-1,131
-12% -$139K 0.04% 359
2021
Q1
$1.11M Sell
9,167
-132
-1% -$15.2K 0.03% 396
2020
Q4
$967K Sell
9,299
-139
-1% -$15.2K 0.04% 355
2020
Q3
$972K Sell
9,438
-2,363
-20% -$249K 0.05% 292
2020
Q2
$1.15M Sell
11,801
-2,390
-17% -$236K 0.06% 264
2020
Q1
$1.21M Sell
14,191
-7,784
-35% -$756K 0.08% 226
2019
Q4
$2.26M Sell
21,975
-6,514
-23% -$626K 0.12% 185
2019
Q3
$2.54M Sell
28,489
-567
-2% -$51.8K 0.15% 158
2019
Q2
$2.69M Sell
29,056
-1,965
-6% -$177K 0.17% 149
2019
Q1
$2.85M Sell
31,021
-33,821
-52% -$3.05M 0.19% 145
2018
Q4
$5.53M Buy
64,842
+28,826
+80% +$2.61M 0.41% 56
2018
Q3
$3.43M Buy
36,016
+32,791
+1,017% +$2.96M 0.23% 129
2018
Q2
$269K Sell
3,225
-1,893
-37% -$157K 0.02% 477
2018
Q1
$416K Sell
5,118
-900
-15% -$76.7K 0.04% 345
2017
Q4
$497K Buy
6,018
+270
+5% +$22.3K 0.04% 316
2017
Q3
$469K Sell
5,748
-2,271
-28% -$182K 0.05% 313
2017
Q2
$635K Sell
8,019
-768
-9% -$58.5K 0.07% 253
2017
Q1
$651K Sell
8,787
-1,270
-13% -$92.6K 0.07% 225
2016
Q4
$693K Sell
10,057
-723
-7% -$50.2K 0.09% 204
2016
Q3
$777K Buy
10,780
+3,950
+58% +$291K 0.1% 191
2016
Q2
$492K Buy
6,830
+463
+7% +$32.6K 0.07% 241
2016
Q1
$436K Buy
+6,367
New +$426K 0.07% 257

Other funds holding XLV

Geneos Wealth Management's XLV Position: Q1 2026 in Review

Geneos Wealth Management reduced its State Street Health Care Select Sector SPDR ETF (XLV) stake by 4.6% in Q1 2026, selling an estimated $62.9K and leaving 8,465 shares worth $1.24M. The position accounts for 0.03% of the portfolio, ranked #459.

Geneos Wealth Management first reported a position in XLV in Q1 2016 and has held it in 41 quarters since. The position peaked at $7.81M in Q1 2025. 1,804 funds tracked by Wall St. Rank hold XLV as of Q1 2026.

  • Geneos Wealth Management held 8,465 shares of State Street Health Care Select Sector SPDR ETF worth $1.24M as of Q1 2026.
  • Geneos Wealth Management sold 408 State Street Health Care Select Sector SPDR ETF shares in Q1 2026, an estimated $62.9K.
  • State Street Health Care Select Sector SPDR ETF made up 0.03% of Geneos Wealth Management's portfolio in Q1 2026, its #459 holding.
  • Geneos Wealth Management first reported a position in State Street Health Care Select Sector SPDR ETF in Q1 2016 and has held it in 41 quarters since.
  • Geneos Wealth Management's State Street Health Care Select Sector SPDR ETF position peaked at $7.81M in Q1 2025.
  • 1,804 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.